Nu-Med Plus (NUMD, $0.05) was a top loser over the last three months, falling -3 to $0.05 per share. A.I.dvisor analyzed 455 stocks in the Medical Specialties Industry for the 3-month period ending June 5, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.